Virpax Pharmaceuticals Inc (VRPX) Return on Investment ROI from the fourth quarter of 2024 to fourth quarter of 2023 and for the year 2024, average high and low, overall ranking from Dec 31 2024 to Dec 31 2023 - CSIMarket
CSIMarket
 


Virpax Pharmaceuticals Inc   (NASDAQ: VRPX)


Virpax Pharmaceuticals Inc's ROI from its fourth quarter of 2024 to the fourth quarter of 2023 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Virpax Pharmaceuticals Inc's ROI in the fourth quarter of 2024?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Virpax Pharmaceuticals Inc 's return on investment (ROI) in its fourth quarter of 2024

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
Y / Y Investment Change TTM - - -87.41 % -70.44 % -58.63 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -1 -2 -3 -1 5
Return On Investment (TTM) - - - - -153.8 %
VRPX's Overall Ranking # # # # #
Seq. Investment Change TTM - - -65.38 % -41.54 % -21.91 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -13 -17 -17 -15




Return On Investment VRPX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Virpax Pharmaceuticals Inc's IV. Quarter Investments $ -1 Millions VRPX's Balance sheet
Virpax Pharmaceuticals Inc's IV. Quarter Income $ -3 Millions Quarterly VRPX's Income Statement
VRPX's Income by Division See VRPX's Income by Division


VRPX Annual Return On Investment (Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021

Total Investments in Millions -1 5 17 37 0
Y / Y Investment Growth - -66.85 % -55.77 % - -
Net Income in Millions -12 -15 -22 -12 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -276.36 % -130.59 % -32.16 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VRPX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VRPX's Competitors
Subscribers only: Roi for Virpax Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for VRPX's Customers

Other Ratios
VRPX's Roa VRPX's Inventory Turnover Ratio VRPX's Growth Rates VRPX's Dividend Statistics
VRPX's Profitability Ratios VRPX's Asset Turnover Ratio VRPX's Dividend Growth
VRPX's Roe VRPX's Valuation Ratios VRPX's Financial Strength Ratios VRPX's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2024, within Healthcare Sector ROI
Interpace Biosciences Inc   1,146.96 %
Inhibrx Biosciences Inc   894.58 %
Traws Pharma inc   659.53 %
Ir med Inc   445.51 %
Polypid Ltd  278.02 %
Inspira Technologies Oxy B H N Ltd  235.17 %
Camp4 Therapeutics Corporation  206.47 %
Alumis inc   156.42 %
Longduoduo Co Ltd  152.69 %
Pavmed Inc   149.32 %


Date modified: 2026-06-22T14:32:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.